U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
15348115348124 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. GlargineCompletedNo Results AvailableType 2 DiabetesDrug: Lispro mix 75/25|Drug: Glarginehttps://ClinicalTrials.gov/show/NCT00551538
153482153482Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerActive, not recruitingNo Results AvailableProstate CancerRadiation: 3-dimensional conformal radiation therapy (3D-CRT)|Radiation: intensity-modulated radiation therapy (IMRT)|Radiation: samarium Sm 153 lexidronam pentasodiumhttps://ClinicalTrials.gov/show/NCT00551525
153483153483Phase I Clinical and Pharmacokinetic (PK) Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid TumorsCompletedNo Results AvailableCancer|Solid TumorsDrug: CBP501 and Cisplatinhttps://ClinicalTrials.gov/show/NCT00551512
153484153484Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHFCompletedNo Results AvailableHeart Failure|Central Sleep ApneaDevice: CRT in combination with Atrial Overdrive Pacinghttps://ClinicalTrials.gov/show/NCT00551499
153485153485Pyrosequencing of the BRAFV600E MutationCompletedNo Results AvailableThyroid NeoplasmsProcedure: ultrasound-guided fine needle aspiration biopsyhttps://ClinicalTrials.gov/show/NCT00551486
153486153486Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.CompletedNo Results AvailableGastroesophageal Reflux Disease|Reflux, GastroesophagealDrug: Lavoltidinehttps://ClinicalTrials.gov/show/NCT00551473
153487153487S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic LeukemiaActive, not recruitingNo Results AvailableLeukemiaDrug: arsenic trioxide|Drug: gemtuzumab ozogamicin|Drug: mercaptopurine|Drug: methotrexate|Drug: tretinoinhttps://ClinicalTrials.gov/show/NCT00551460
153488153488A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)CompletedNo Results AvailableCoronary DiseaseDrug: MK0653, ezetimibe / Duration of Treatment: 27 Weeks|Drug: MK0733, simvastatin / Duration of Treatment: 27 Weeks|Drug: Comparator: simvastatin / Duration of Treatment: 27 Weekshttps://ClinicalTrials.gov/show/NCT00551447
153489153489Effect of Creatine and L-Arginine on Endothelial FunctionCompletedNo Results AvailableCoronary Artery DiseaseDietary Supplement: Creatine|Dietary Supplement: L-arginine and creatine|Dietary Supplement: l-arginine|Dietary Supplement: placebo, doublehttps://ClinicalTrials.gov/show/NCT00551434
153490153490Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerCompletedHas ResultsAdenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal CancerBiological: pertuzumab|Biological: cetuximab|Drug: irinotecan hydrochloride|Other: immunohistochemistry staining method|Other: fluorescence in situ hybridization|Other: gene expression analysis|Other: mutation analysis|Other: polymerase chain reaction|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00551421
153491153491Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial HypertensionActive, not recruitingNo Results AvailablePulmonary Idiopathic Arterial Hypertensionhttps://ClinicalTrials.gov/show/NCT00551408
153492153492Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late CompletionTerminatedNo Results AvailableGlaucomaProcedure: selective laser trabeculoplasty - early completion|Procedure: Selective laser trabeculoplasty - late completionhttps://ClinicalTrials.gov/show/NCT00551395
153493153493Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled StudyRecruitingNo Results AvailableUpper Respiratory Tract InfectionDrug: Muntelukast|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00551382
153494153494Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By SurgeryActive, not recruitingNo Results AvailableLung CancerProcedure: conventional surgery|Radiation: stereotactic body radiation therapyhttps://ClinicalTrials.gov/show/NCT00551369
153495153495Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCompletedNo Results AvailableDiabetes Mellitus Type 2Drug: Insulin lispro mix 25|Drug: Glarginehttps://ClinicalTrials.gov/show/NCT00551356
153496153496Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi SyndromeRecruitingNo Results AvailablePrader-Willi SyndromeDrug: Exenatidehttps://ClinicalTrials.gov/show/NCT00551343
153497153497Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)CompletedNo Results AvailableHIV Infections|Acquired Immunodeficiency SyndromeDrug: Vicriviroc|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00551330
153498153498A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese MenCompletedNo Results AvailableAtherosclerosisDrug: Darapladib (SB480848)https://ClinicalTrials.gov/show/NCT00551317
153499153499Native Kidney Denervation in Patients With End Stage Renal DiseaseCompletedNo Results AvailableEnd Stage Renal DiseaseDevice: Ardian Catheterhttps://ClinicalTrials.gov/show/NCT00551304
153500153500A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.CompletedNo Results AvailableMyelodysplastic SyndromesDrug: CellCept|Drug: Prednisone|Drug: epoetin beta [NeoRecormon]https://ClinicalTrials.gov/show/NCT00551291
153501153501Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast CancerCompletedNo Results AvailableBreast CancerDevice: GeneSearchâ„¢ Breast Lymph Node (BLN) Assayhttps://ClinicalTrials.gov/show/NCT00551278
153502153502Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyWithdrawnNo Results AvailableFallopian Tube Carcinoma|Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian CancerBiological: Oregovomab|Drug: Cyclophosphamide|Procedure: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00551265
153503153503A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant MesotheliomaNot yet recruitingNo Results AvailableMesotheliomaDrug: Imatinib mesylate plus Gemcitabinehttps://ClinicalTrials.gov/show/NCT00551252
153504153504Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaActive, not recruitingNo Results AvailableLeukemia|LymphomaBiological: rituximab|Drug: fludarabine phosphate|Drug: pixantrone dimaleatehttps://ClinicalTrials.gov/show/NCT00551239
153505153505Follow up of Autoantibodies in Active TuberculosisNot yet recruitingNo Results AvailableTuberculosishttps://ClinicalTrials.gov/show/NCT00551226
153506153506A Study to Determine the Activity of SCH 717454 in Subjects With Relapsed or Recurrent Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: SCH 717454|Drug: Chemotherapyhttps://ClinicalTrials.gov/show/NCT00551213
153507153507Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle DisordersCompletedHas ResultsUrea Cycle DisordersDrug: HPN-100|Drug: BUPHENYL®https://ClinicalTrials.gov/show/NCT00551200
153508153508A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)CompletedNo Results AvailableCervical Cancer|Vulvar Cancer|Vaginal Cancer|Genital Warts|Human Papillomavirus InfectionBiological: V504|Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine|Biological: Comparator: Placebo (unspecified)https://ClinicalTrials.gov/show/NCT00551187
153509153509A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva TreatmentCompletedHas ResultsPost-Menopausal OsteoporosisDrug: ibandronate [Bonviva/Boniva]|Drug: ibandronate [Bonviva/Boniva]https://ClinicalTrials.gov/show/NCT00551174
153510153510Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's DiseaseCompletedHas ResultsAlzheimer DiseaseDrug: memantinehttps://ClinicalTrials.gov/show/NCT00551161

* Görseller ve İçerik tekif hakkına sahip olabilir